NPS MedicineWise Learning
Audit and feedback – Chronic kidney disease: early detection and management
A series of quality improvement clinical audits
- General practitioners (GPs)
- Health professionals working in remote areas with extended scope of practice*
*While these clinical audits are primarily targeted at GPs, health professionals who work in rural or remote areas with extended scope of practice could complete these in collaboration with appropriate clinical staff.
CPD points: Self-recorded: See details
One in 10 Australian adults have signs of probable chronic kidney disease (CKD) and less than 10% of those affected are aware they may have the condition.
Knowing who is at risk of CKD allows targeted screening and early diagnosis. Early detection and intervention may slow or halt disease progression to help avoid dialysis and kidney transplant, and reduce absolute cardiovascular risk.
NPS MedicineWise has developed a series of three audit and feedback activities focused on the diagnosis and management of CKD. See Figure 1
Figure 1: NPS MedicineWise audit and feedback activities – CKD.
You can choose to complete any or all of the audit and feedback activities, although completion in a sequential order is recommended.
What do I get out of this activity?
Each audit and feedback activity allows you to assess and review your management of patients at risk of, or who have, CKD, then make a comparison between your current management and best practice recommendations.
- Complete data collection for patients within your practice/clinic.
- Review your practice/clinic data compared to national aggregate data.
- Review individual patients’ data, against best practice clinical indicators.
- Identify and implement improvements in your practice.
Figure 2: NPS MedicineWise audit and feedback cycle
Clinical resources and tools
The NPS MedicineWise Educational Visit – Chronic kidney disease: early detection and management provides the foundation for the audit and feedback activities. If you were not able to receive an educational visit, review the supporting clinical resources available here prior to starting the audit and feedback activity.
Audit and feedback activities
Chronic kidney disease: Audit and feedback activity 1 – Screening
This activity allows you to screen patients at risk of CKD and identify those with early signs of the disease.
Chronic kidney disease: Audit and feedback activity 2 – Diagnosis and management
This activity allows you to review your approach to the diagnosis and the management of CKD.
Chronic kidney disease: Audit and feedback activity 3 – Pharmacological management
This activity allows you to optimise your prescribing for CKD, including the use of:
- angiotensin-converting enzyme (ACE) inhibitors / angiotensin II receptor blockers (ARBs) and
- sodium-glucose co-transporter-2 (SGLT2) inhibitors to treat those with CKD and type 2 diabetes.
Continuing professional development
This audit and feedback activity can be self-recorded for professional development hours. The audit’s duration will vary depending on the GP, their practice and the number of patients reviewed. NPS MedicineWise recommends allowing approximately 3–8 hours per 5–10 patients to complete each audit. There are three audits available to choose from.